A blocking peptide containing 21 amino acids near the carboxy terminus of human DC-SIGN.
Points forts
Source
Synthetic
(Accession #: Q9NNX6) The DC-SIGN/CD209 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-081849 |
|---|
| Réf. fabricant | 18244387 |
|---|
| Gene ID (Entrez) | 30835 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-77284. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | CD209 antigendendritic cell-specific intracellular adhesion molecules (ICAM)-3 grabbingnon-integrin, CD209 molecule, CDSIGNHIV gpl20-binding protein, CLEC4LC-type lectin domain family 4 member L, DC-SIGN1C-type lectin domain family 4, member L, DC-SIGNMGC129965, Dendritic cell-specific ICAM-3-grabbing non-integrin 1 |
|---|
| Symbole de gène(s) | CD209 |
|---|
| Type de produit | DC-SIGN/CD209 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 21 amino acids near the carboxy terminus of human DC-SIGN |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
